Virtu KCG Holdings’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-80,918
| Closed | -$44K | – | 4184 |
|
2016
Q3 | $44K | Buy |
80,918
+48,228
| +148% | +$26.2K | ﹤0.01% | 2799 |
|
2016
Q2 | $19K | Buy |
32,690
+17,861
| +120% | +$10.4K | ﹤0.01% | 2793 |
|
2016
Q1 | $22K | Sell |
14,829
-30,724
| -67% | -$45.6K | ﹤0.01% | 2580 |
|
2015
Q4 | $146K | Buy |
+45,553
| New | +$146K | ﹤0.01% | 2347 |
|
2015
Q3 | – | Sell |
-32,208
| Closed | -$320K | – | 3782 |
|
2015
Q2 | $320K | Buy |
32,208
+15,800
| +96% | +$157K | 0.01% | 1593 |
|
2015
Q1 | $121K | Buy |
16,408
+2,057
| +14% | +$15.2K | ﹤0.01% | 2102 |
|
2014
Q4 | $77K | Sell |
14,351
-17,489
| -55% | -$93.8K | ﹤0.01% | 2421 |
|
2014
Q3 | $160K | Buy |
31,840
+476
| +2% | +$2.39K | ﹤0.01% | 2173 |
|
2014
Q2 | $211K | Buy |
+31,364
| New | +$211K | ﹤0.01% | 2056 |
|